Skip to Content
Merck
  • Type II NADH dehydrogenase of the respiratory chain of Plasmodium falciparum and its inhibitors.

Type II NADH dehydrogenase of the respiratory chain of Plasmodium falciparum and its inhibitors.

Bioorganic & medicinal chemistry letters (2008-12-23)
Carolyn K Dong, Vishal Patel, Jimmy C Yang, Jeffrey D Dvorin, Manoj T Duraisingh, Jon Clardy, Dyann F Wirth
ABSTRACT

Plasmodium falciparum NDH2 (pfNDH2) is a non-proton pumping, rotenone-insensitive alternative enzyme to the multi-subunit NADH:ubiquinone oxidoreductases (Complex I) of many other eukaryotes. Recombinantly expressed pfNDH2 prefers coenzyme CoQ(0) as an acceptor substrate, and can also use the artificial electron acceptors, menadione and dichlorophenol-indophenol (DCIP). Previously characterized NDH2 inhibitors, dibenziodolium chloride (DPI), diphenyliodonium chloride (IDP), and 1-hydroxy-2-dodecyl-4(1H)quinolone (HDQ) do not inhibit pfNDH2 activity. Here, we provide evidence that HDQ likely targets another P. falciparum mitochondrial enzyme, dihydroorotate dehydrogenase (pfDHOD), which is essential for de novo pyrimidine biosynthesis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Flavone, ≥99.0%
Supelco
Menadione (K3), analytical standard
Supelco
Rotenone, PESTANAL®, analytical standard
Sigma-Aldrich
Diphenyliodonium hexafluorophosphate, ≥98%
Sigma-Aldrich
Diphenyliodonium nitrate
Sigma-Aldrich
Diphenyliodonium chloride, ≥98.0% (AT)
Sigma-Aldrich
Indophenol
Sigma-Aldrich
Menadione, crystalline
Sigma-Aldrich
Menadione, meets USP testing specifications
Sigma-Aldrich
Rotenone, ≥95%